Vision

Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system. 

 

Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood.


News

24 Jul 2024

Epimune presents its novel CD4+ T-helper cell quantification test using dried blood at AIDS 2024


For a Spanish version of this video please click here!